Equities

Lee's Pharmaceutical Holdings Ltd

Lee's Pharmaceutical Holdings Ltd

Actions
  • Price (EUR)0.13
  • Today's Change-0.007 / -5.11%
  • Shares traded--
  • 1 Year change-13.33%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments171189278
Total Receivables, Net185213354
Total Inventory298249331
Prepaid expenses------
Other current assets, total2.19--0
Total current assets657652963
Property, plant & equipment, net443541688
Goodwill, net4.373.903.90
Intangibles, net1,0771,023923
Long term investments6995551,043
Note receivable - long term------
Other long term assets------
Total assets2,8912,7823,637
LIABILITIES
Accounts payable7410163
Accrued expenses5869113
Notes payable/short-term debt00163
Current portion long-term debt/capital leases1308413
Other current liabilities, total387396572
Total current liabilities649650923
Total long term debt758092
Total debt204163267
Deferred income tax737479
Minority interest(78)(82)(73)
Other liabilities, total133136152
Total liabilities8528581,172
SHAREHOLDERS EQUITY
Common stock292929
Additional paid-in capital720720720
Retained earnings (accumulated deficit)3,6873,6803,641
Treasury stock - common------
Unrealized gain (loss)(2293)(2433)(1949)
Other equity, total(105)(72)23
Total equity2,0391,9242,465
Total liabilities & shareholders' equity2,8912,7823,637
Total common shares outstanding589589589
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.